[Asia Economy Reporter Lee Chun-hee] Digital healthcare solution company Ubicare announced on the 7th that it has launched ‘UBIST Analytics,’ a cause analysis solution for pharmaceutical statistical data targeting domestic pharmaceutical companies.
UBIST Analytics is a service that provides in-depth data analysis of statistical results for outpatient prescription drugs. This is the first domestic launch of such a service. From the user’s perspective, it is designed as a data analysis solution that easily derives personalized data based on various comprehensive domestic information including marketing activities of both the company and competitors, news, and official announcements.
The service offers features such as △statistical analysis of data by units including ATC, ingredient, brand, and drug △data analysis by periods such as month, quarter, and half-year △filtering analysis based on five types of comprehensive information including news, official announcements, clinical data, patents, and academic conferences. Additionally, it includes user convenience features such as advanced analysis for creating custom markets per user and favorites.
Lee Sang-kyung, CEO of Ubicare, said, “With the launch of UBIST Analytics, Ubicare will accelerate the expansion of its data business by utilizing healthcare big data it possesses. We will provide a service that can be used by a wide range of departments including market research teams within pharmaceutical companies, as well as marketing, research and development, and sales support, who are our existing major customers.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
